Last reviewed · How we verify

NCT03260348

Acute Respiratory Distress Syndrome in Taiwan

Status unknown Last updated 24 August 2017
What this trial tests

trial in Acute Respiratory Distress Syndrome in 2,000 participants. Status unknown.

Timeline
1 September 2017
Primary endpoint
31 January 2018
31 January 2023

Quick facts

Lead sponsorChang Gung Memorial Hospital
StatusStatus unknown
Study typeOBSERVATIONAL
Enrollment2,000
Start date1 September 2017
Primary completion31 January 2018
Estimated completion31 January 2023

Conditions studied

Sponsor

Chang Gung Memorial Hospital

Who can join

18 and older, any sex, with Acute Respiratory Distress Syndrome. Patients with the condition only — healthy volunteers not accepted.

Sponsor's own description

The study enrolls ARDS patients in medical ICUs in 11 Hospitals in Taiwan. The epidemiology and long-term outcomes of the patients will be recorded.

Publications & conference data

No peer-reviewed publications indexed yet for this trial.

Verify or expand the search:

Other recruiting trials for Acute Respiratory Distress Syndrome

Currently open trials in the same condition.

Other Chang Gung Memorial Hospital trials

Trials by the same sponsor.

Verify against primary sources

Data sources for this page

Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT03260348.

Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing